{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-21-024381","form_type":"8-K","ticker":"IDXG","cik":"0001054102","company_name":"INTERPACE BIOSCIENCES, INC.","filed_at":"2021-10-01T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.292641+00:00","generated_at":"2026-06-28T23:44:06.924433+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Interpace Biosciences extends maturity of $7.5M in secured notes to October 31, 2021","bullets":["Ampersand Note principal $4.5M, 1315 Capital Note $3.0M; total $7.5M in secured debt.","Maturity date extended one month from September 30, 2021 to October 31, 2021.","This is the fourth amendment to each note; terms otherwise unchanged.","Security agreement remains in full force and effect.","Noteholders are related parties holding convertible preferred shares (39% and 26% fully diluted combined)."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-21-024381","json":"https://secwatch.observer/filing/0001493152-21-024381.json","markdown":"https://secwatch.observer/filing/0001493152-21-024381.md","text":"https://secwatch.observer/filing/0001493152-21-024381.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1054102/000149315221024381/0001493152-21-024381-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1054102/000149315221024381/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T23:44:06.924433+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}